Close Menu

NEW YORK (GenomeWeb) - Biocept today after the close of the market reported a 300 percent increase year over year in its fourth quarter revenues.

For the three months ended Dec. 31, 2014, Biocept's total revenues increased to $76,000 from $19,000 in the prior-year fourth quarter, primarily related to higher commercial test volume, the firm said in a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.